Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES…Department of Health and Human Services$68.0M obligationsEnds Jul 28, 2027
1500006I DUKE UNIVERSITY; TO 18-0006.B1.0115--06 BASE AWARD; BIOD CAN 8470038 $55,158Department of Health and Human Services$2.4M obligationsEnds Jul 31, 2025
PHASE 1 CLINICAL TRIALDepartment of Health and Human Services$109.7K obligationsEnds Dec 14, 2021
IGF::OT::IGF VTEU PROTOCOL DEVELOPMENT, IMPLEMENTATION AND ASSAYS TASK AREA B-D POPULATION PHARMACOKINETIC ANALYSES TASK ORDER FY.2017.B2C2D2.0053.Department of Health and Human Services$1.1M obligationsEnds Nov 30, 2022
THE PURPOSE OF THIS TASK ORDER IS TO (A) ACQUIRING, PROCURING AND/OR MANUFACTURING MATERIALS REQUIRED FOR THE GENERATION OF A SCALABLE IN VITRO TRANSCRIPTION (IVT) REACTION, THE…Department of Health and Human Services$6.8M obligationsEnds Mar 28, 2027
IGF::OT::IGF NIAID VIROLOGY QUALITY ASSURANCE (VQA)Department of Health and Human Services$24.0M obligationsEnds Jun 20, 2026
IGF::OT::IGF EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL)Department of Health and Human Services$35.8M obligationsEnds Sep 29, 2024
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020)Department of Health and Human Services$35.6M obligationsEnds Dec 31, 2030
IGF::OT::IGF NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENTDepartment of Health and Human Services$6.1M obligationsEnds Dec 14, 2024
"ADVANCED DEVELOPMENT OF A NEUTRALIZING ANTIBODY VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES"Department of Health and Human Services$18.2M obligationsEnds May 31, 2028
INNOVATIONS IN FUNCTIONAL B CELL EPITOPE DISCOVERYDepartment of Health and Human Services$4.6M obligationsEnds Sep 29, 2027
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENTDepartment of Health and Human Services$5.1M obligationsEnds Mar 29, 2027
ADJUVANT COMPARISON AND CHARACTERIZATIONDepartment of Health and Human Services$8.5M obligationsEnds Apr 30, 2028
PROMOTING T CELL RECOVERY AFTER RADIATION INJURY WITH LONG-ACTING INTERLEUKIN 7Department of Health and Human Services$3.5M obligationsEnds Feb 28, 2027
VIROLOGY CORE LABORATORYDepartment of Health and Human Services$1.9M obligationsEnds Dec 14, 2026
FEASIBILITY FOR DEVELOPMENT OF A LIPOSOME/LNP DISPLAYING AN HIV ENV TRIMER PROTEIN AND CONTAINING/INCORPORATING AN MRNADepartment of Health and Human Services$5.9M obligationsEnds Aug 27, 2028
IGF::OT::IGF NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENTDepartment of Health and Human Services$18.0M obligationsEnds Mar 29, 2025
EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL)Department of Health and Human Services$12.1M obligationsEnds Sep 29, 2027
VIROLOGY QUALITY ASSURANCE (VQA)Department of Health and Human Services$3.4M obligationsEnds Jun 20, 2027
TASK ORDER 75N93022F00001 BASE AWARDDepartment of Health and Human Services$959.5K obligationsEnds Jan 13, 2027
RESEARCH AND DEVELOPMENT PRODUCT STORAGE AND SHIPPINGDepartment of Health and Human Services$2.9M obligationsEnds Nov 30, 2026
1500006I DUKE UNIVERSITYDepartment of Health and Human Services$106.5K obligationsEnds Dec 14, 2020
IGF::OT::IGF1300017I DUKE UNIVERSITY; TASK ORDER HHSN27200008-14-0053.A1B1C1D1.0026- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL IN ADULTS WITH COMMUNITY…Department of Health and Human Services$12.0M obligationsEnds Dec 31, 2024
IGF::OT::IGF 1300017I DUKE UNIVERSITY; VTEU; TO A4D14.0033--17 CONSULTATION AND TESTING OF CYTOKINE LEVELS AND CELL ACTIVATION IN CLINICAL SAMPLESDepartment of Health and Human Services$1.8M obligationsEnds Dec 31, 2023
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY COREDepartment of Health and Human Services$78.2M obligationsEnds Sep 15, 2028